Sexual Dimorphism in Outcomes of Non–muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint

BACKGROUND: Non–muscle-invasive bladder cancer (NMIBC) is over three times as common in men as it is in women; however, female patients do not respond as well to immunotherapeutic treatments and experience worse clinical outcomes than their male counterparts. Based on the established sexual dimorphi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chenard, Stephen, Jackson, Chelsea, Vidotto, Thiago, Chen, Lina, Hardy, Céline, Jamaspishvilli, Tamara, Berman, David, Siemens, D. Robert, Koti, Madhuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Bladder Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317911/
https://www.ncbi.nlm.nih.gov/pubmed/34337534
http://dx.doi.org/10.1016/j.euros.2021.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317911/
https://www.ncbi.nlm.nih.gov/pubmed/34337534
http://dx.doi.org/10.1016/j.euros.2021.05.002

Ejemplares similares